NCT01532687 2021-09-27Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue SarcomaOHSU Knight Cancer InstitutePhase 2 Completed54 enrolled 12 charts
NCT00297258 2016-02-03Pazopanib In Patients With Relapsed Or Refractory Soft Tissue SarcomaGlaxoSmithKlinePhase 2 Completed148 enrolled 8 charts